Uloric Side Effects Lawsuit

Nadrich & Cohen hopes that you and your family stay safe during this stressful time. Our law firm continues to serve our existing clients and is accepting new cases. Our full team is still available to serve you. Our phones are answered 24/7.... If you have an injury claim or question, call us for a free consultation, visit our website, or send us a message on social media. We're here to help.

Nadrich & Cohen hopes that you and your family stay safe during this stressful time. Our law firm continues to serve our existing clients and is accepting new cases. Our full team is still available to serve you. Our phones are answered 24/7.... If you have an injury claim or question, call us for a free consultation, visit our website, or send us a message on social media. We're here to help.

A higher rate of cardiovascular fatal outcomes has been reported in patients with gout and established cardiovascular disease treated with ULORIC, when compared to those treated with other medications.

A whistleblower says that he believes that FDA inspectors detect only a fraction of problematic practices at overseas factories.

The FDA advisory committees voted 19-2 that Uloric risks are outweighed by Uloric’s benefits in certain patient populations.

The U.S. Food and Drug Administration (FDA) has concluded there is an increased risk of death with Uloric (febuxostat) compared to another gout medicine, allopurinol.

Faced with the problem of cardiovascular mortality, experts recommended several regulatory actions such as an additional black box warning and a change in the indication to make febuxostat (Uloric) a second-line therapy after allopurinol.

The FDA has concluded there is an increased risk of death with Uloric (febuxostat) compared to other gout medications.